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Abstract Atrophy or hypofunction of the salivary gland
because of aging or disease leads to hyposalivation that
affects patient quality of life by causing dry mouth, dete-
rioration of mastication/deglutition, and poor oral hygiene
status. Current therapy for atrophy or hypofunction of the
salivary gland in clinical practice focuses on symptom
relief using drugs and artificial saliva; therefore, there is
still a need to develop new therapies. To investigate
potential novel therapeutic targets, we induced the differ-
entiation of salivary gland cells by co-culturing human
adipose-derived stem cells isolated from buccal fat pads
(hBFP-ASCs) with human salivary-gland-derived fibrob-
lasts (hSG-fibros). We examined their potential for trans-
plantation and tissue neogenesis. Following the culture of
hBFP-ASCs and hSG-fibros, differentiated cells were
transplanted into the submandibular glands of SCID mice,
and their degree of differentiation in tissues was deter-
mined. We also examined their potential for functional
tissue reconstitution using a three-dimensional (3D) culture
system. Co-cultured cells expressed salivary-glandrelated
markers and generated new tissues following transplanta-
tion in vivo. Moreover, cell reconstituted glandular struc-
tures in the 3D culture system. In conclusion, coculture of
hSG-fibros with hBFP-ASCs led to successful differentia-
tion into salivary gland cells that could be transplanted to
generate new tissues.
Keywords Salivary glands  Regenerative  Buccal fat
pads  ASCs  Fibroblasts
Introduction
Atrophy or hypofunction of the salivary gland can occur
following radiotherapy for head and neck cancer, by
obstructive defects in the salivary ducts, in chronic graft-
versus-host disease after bone marrow transplant, or by
age-related changes. Under these conditions, the salivary
gland is markedly impaired, especially acinar cells, and
atrophied or decreased cell numbers causes a loss of
functional parenchymal tissue. This subsequently causes
decreased saliva secretion (dry mouth) which significantly
affects the quality of life due to deterioration of mastica-
tion/deglutition disorder and poor oral hygiene [1–3].
Current therapy for dry mouth caused by atrophy of the
salivary gland in clinical practice is only symptomatic and
includes transiently increasing the secretory capacity of
residual acinar cells by drugs, or moisturizing dry mouth
tissues with artificial saliva. Minimally invasive, radical
therapy to improve quality of life has yet to be established
[3–5].
Here, we examined salivary gland cell differentiation
from stem cells using biomaterials based on a previous study
[6] to develop a less-invasive therapy for dry mouth by
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regenerating salivary gland cells. Previously, mouse-derived
early ES-6 (mEES-6) cells were differentiated by co-culture
with human salivary-gland-derived fibroblasts (hSG-fibros)
to express salivary gland markers [6, 7]. When these cells
were transplanted into normal submandibular glands in
SCIDmice, near-normal salivary gland tissues were formed,
indicating this method induced cell differentiation with
biomaterials alone. Here, we investigated the applicability of
this basic experimental approach to human tissue stem cells
for application in humans.
The oral cavity contains a mass of specialized fatty tissue,
the buccal fat pad (BFP), distinct from subcutaneous fat [8].
Human adipose-derived stem cells from BFP (hBFP-ASCs)
were used as the cell source. The easy accessibility and rich
vascularization of BFP is attractive for grafting, and is used
widely in oral surgery to repair bone and periodontal defects
[9–12]. Harvesting of BFP is a simple procedure requiring
minimal incision and local anesthesia. Salivary gland
fibroblasts were used for induction, even though the degree
of atrophy varied among the collected salivary gland tissues,
because their organ-specific characteristics might induce
organ-derived cells. We investigated the induction and dif-
ferentiation of salivary gland cells using a co-culture system
with hBFP-ASCs and hSG-fibros to determine their use in
cell engraftment.
Materials and methods
Tissue preparation and cell isolation/culture
This study was approved by the Ethics Committee of the
Nippon Dental University, School of Life Dentistry at
Niigata, Japan. Informed consent was obtained preopera-
tively from patients undergoing surgery for salivary gland
cancer, and the minimum necessary amount of tissue was
extracted during surgery. This study adhered to the
amended Declaration of Helsinki. BFP and salivary gland
(submandibular glands) tissues were extracted from four
patients aged 48–54 years.
BFPs were washed in Hanks’ solution (Nissui, Tokyo,
Japan) and minced with a scalpel (Crossfield, Japan). Cells
were dissociated at 37 C for 30 min in 0.01 % collagenase
(Sigma-Aldrich, St. Louis, MO, USA)/0.05 % dispase
(Life Technologies, Carlsbad, CA, USA), centrifuged, and
the stromal vascular fraction [13] was cultured. To isolate
undifferentiated cells, CD31? (vascular component mar-
ker) cells (Miltenyi Biotec, Tokyo, Japan) were depleted by
magnetic-activated cell sorting (Miltenyi Biotec). CD31-
cells were further isolated from the stromal vascular frac-
tion of BFPs, cultured, and used as hBFP-ASCs. Cell
identification was performed by cell surface marker anal-
ysis [14] and pluripotency evaluation [11].
Normal salivary gland tissues were washed with Hanks’
solution, sliced with a razor-type scalpel, and strips were
cultured under static conditions. Outgrowing fibroblasts
were separated by colonial cloning using the filter paper
(Toyo Roshi Kaisha, Japan) method [15]. These cells were
considered hSG-fibros, and after identification were used
for immunostaining and RT-PCR. These cells were cul-
tured in growth medium (GM) [Dulbecco’s modified
Eagle’s medium (DMEM)/F12 (Life Technologies) sup-
plemented with 15 % fetal bovine serum (FBS; Life
Technologies), 10 lM non-essential amino acid solution
(Life Technologies), 100 U/ml penicillin, 50 lg/ml strep-
tomycin (Life Technologies), and 0.25 lg/ml amphotericin
B (Fungizone; Life Technologies)] in a CO2 incubator
(4.7 % CO2 ? 95.3 % air). GM was changed twice
weekly. During culture, cells were observed by inverted-
phase contrast microscope (Olympus, Tokyo, Japan). For
primary culture and subculture, 0.2 % trypsin–0.02 %
EDTA/PBS(–) solution (Trypsin 250; Difco, Detroit, MI,
USA) and Hanks’ solution were used. Cells were cultured
in 60-mm dishes (Falcon Plastics, Franklin Lakes, NJ,
USA). Manipulation of cellular aggregates in culture (pri-
mary culture, subculture, and cryopreservation) was
accomplished using 5-ml disposable pipettes (Nippon
Genetics, Tokyo, Japan) and 15-ml (Greiner-bio-one,
Tokyo, Japan) and/or 50-ml centrifuge tubes (Falcon
Plastics).
Cell surface analysis
Cell-surface analysis of hBFP-ASCs was by flow cytome-
try [14]. Fluorescein isothiocyanate (FITC)-conjugated
mouse monoclonal antibodies against CD14, CD90 and
CD105 (Abcam, Cambridge, MA, USA) and CD34 and
CD44 (Becton & Dickinson, San Jose, CA, USA) were
used. Phycoerythrin-conjugated mouse IgG1 (Becton &
Dickinson) was used as a negative control. Data acquisition
and analyses were performed with Guava Express Plus
(version 5.3) software (EMD Millipore Corporation, Bil-
lerica, MA, USA).
Multilineage cell differentiation
hBFP-ASCs were induced to differentiate in osteogenic,
adipogenic or chondrogenic medium for several weeks. To
induce multilineage differentiation, hBFP-ASCs were
seeded at 1 9 105 cells per well in 6-well plates and
maintained in GM until confluent. Induction and control
media were changed twice weekly [11].
For osteogenic differentiation, hBFP-ASCs were cultured
in DMEM, high-glucose (DMEM-hg; Life Technologies)
supplemented with 15 % FBS, 10 nM dexamethasone
(Sigma-Aldrich), 10 mM b-glycerophosphate (Wako Pure
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Chemical Industries, Osaka, Japan), and 100 lM ascorbate-
2-phosphate (Wako Pure Chemical Industries). Osteogene-
siswas confirmed by stainingwith 1 %alizarin red S (Merck,
Darmstadt, Germany) for calcium deposition.
For adipogenic differentiation, hBFP-ASCs were cul-
tured in DMEM-hg supplemented with 15 % FBS, 0.5 mM
isobutylmethylxanthine (Wako Pure Chemical Industries),
1 lM dexamethasone (Sigma-Aldrich), and 100 lM indo-
methacin (Sigma-Aldrich). Adipogenesis was confirmed by
staining with Oil red-O (Sigma-Aldrich).
For chondrogenic differentiation, hBFP-ASCs were
cultured in DMEM-hg supplemented with 1 % FBS,
6.25 lg/ml insulin (Wako Pure Chemical Industries),
10 ng/ml transforming growth factor-b1 (Peprotech, Rocky
Hill, NJ, USA), and 50 nM ascorbate-2-phosphate (Wako
Pure Chemical Industries). Chondrogenesis was confirmed
by staining with toluidine blue (Muto Pure Chemicals Co.
Ltd., Tokyo, Japan). Control cultures were maintained in
DMEM supplemented with 15 % FBS lacking induction
supplements.
Induction of differentiation into salivary gland cells
by co-culture
Co-SG cells were induced by co-culture with hBFP-ASCs
and hSG-fibros. Before co-culture, the growth potential of
hSG-fibros was eliminated by mitomycin C (10 lg/ml;
Kyowa Hakko Kirin, Tokyo, Japan) in GM [16, 17]. Then,
hSG-fibros were washed using Hanks’ solution and co-
cultured with hBFP-ASCs. Co-culture medium was chan-
ged twice weekly. No differentiation-inducing materials
were used. After co-culturing for 1 week, cultured cell
morphology changed, and cells were isolated by colonial
cloning. Filter paper soaked with trypsin 250 solution was
placed directly onto clusters cells, then removed from
plastic dishes, shaken into a fresh plastic dish where cells
were transferred to medium [15], and subculture was
continued. Cultured cells after cloning (co-SG cells) were
used within three passages of culture for analysis and
experiments. Salivary amylase activity of differentiated
cells was measured by amylase assay (Abcam).
Co-SG cell transplantation in vivo
Co-SG cells were transplanted into normal submandibular
glands of mice (Jcl scid/scid 8-weeks-old, female; CLEA
Japan, Japan) to examine whether co-SG cells that differ-
entiated by co-culture with human-derived cells could be
engrafted in vivo, and whether the cells differentiated into
salivary glands in vivo. Under anesthesia, co-SG cells
(1 9 105 cells/0.2 ml Hanks’ solution/mouse) were injec-
ted with a 23-G needle through an incision into sub-
mandibular glands. Mice were euthanized approximately
1 month after transplantation, and transplanted sub-
mandibular glands were harvested. Methods for animal
husbandry and sacrifice conformed to the code of ethics for
experimental animals of the Nippon Dental University
School of Life Dentistry at Niigata, Japan (Approval No.
139).
Reconstitution of salivary gland tissues
Tissue reconstitution was examined by three-dimensional
(3D) culture system to determine whether salivary gland-
like tissue structures formed in vitro. For tissue reconsti-
tution, hBFP-ASCs and hSG-fibros were 3D co-cultured
with a collagen sponge (type I collagen sponge; Stem Inc.,
Tokyo, Japan). For culture, hSG-fibros were injected into
the collagen sponge soaked in GM. After culture under
static conditions for 2 weeks, cells were colonized, and co-
SG cells differentiated from co-culture of hBFP-ASCs with
hSG-fibros were injected into a collagen sponge colonized
with hSG-fibros. After culture under static conditions for
1 week, the sponge was transferred to continuous culture
(6 ml/min) by circumfusion apparatus to maintain a con-
stant culture environment for 3 weeks. Medium (200 ml/
bottle) was changed every 3 days. Cultured tissues were
examined histologically. Salivary amylase activity was
measured in reconstructed tissues.
Chromosome analysis
Direct chromosome preparation was performed in the
exponential growth phase of co-SG cells at passage 3.
Subconfluent cells were incubated with 100 nM colcemid
(Sigma-Aldrich) for 4 h at 37 C, then harvested and
centrifuged. Cells were resuspended in 70 mM KCl (Wako
Pure Chemical Industries) at 1 9 104 cells/ml for 20 min at
37 C, centrifuged, and fixed with freshly prepared
methanol:acetic acid (3:1; Wako Pure Chemical Industries)
solution for 5 min at room temperature. Next, cells were
centrifuged, and the supernatant was discarded. The pellet
was incubated overnight at 4 C and then fixed in metha-
nol:acetic acid solution. Cell suspension in fixative was
dropped onto a wet, cold micro-glass slide and stained with
Giemsa solution (Wako Pure Chemical Industries). Fifty
mitotic figures were chosen randomly, analyzed and
counted for distribution and karyotype.
Histological examination
Thoracotomy was performed under general anesthesia to
harvest tissues from mice. After perfusion with Hanks’
solution, perfusion fixation was achieved with 4 %
paraformaldehyde. Submandibular glands were extirpated,
embedded in fixing solution, dehydrated, and embedded in
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paraffin. Tissue sections were prepared at 4-lm thickness
for hematoxylin and eosin (HE; Wako Pure Chemical
Industries) staining, Periodic Acid Schiff’s (PAS, Wako
Pure Chemical Industries) staining, and immunohisto-
chemistry (after deparaffinization). After washing with
PBS (Takara Bio, Japan), samples were activated in 0.1 %
trypsin at 37 C for 30 min and blocked with 1 % bovine
serum albumin (Sigma-Aldrich) at room temperature for
30 min. Samples were incubated with the following pri-
mary antibodies at 4 C overnight: monoclonal mouse anti-
human mitochondria (1:1000, Sigma-Aldrich); polyclonal
rabbit anti-human amylase (1:500, Sigma-Aldrich); and
polyclonal rabbit anti-mouse aquaporin 5 (AQP-5, 1:1000,
Abcam). After washing with PBS, samples were incubated
with anti-mouse or anti-rabbit fluorescein-conjugated sec-
ondary antibodies (diluted 1:1000, Alexa Fluor; Life
Technologies) at room temperature for 2 h. For nuclear
staining and inclusion, Vectashield mounting medium with
DAPI (Vector Laboratories, Burlingame, CA, USA) was
used. For negative controls, primary antibody was omitted
during immunostaining.
Immunocytochemistry
hSG-fibros and co-SG cells during passage 3 were seeded
in Laboratory-Tek II chamber slides (Nalge Nunc, Ros-
kilde, Denmark), cultured in GM, and stained 3–4 days
later. Cells were fixed in 100 % methanol (Wako Pure
Chemical Industries) at -30 C for 10 min, washed with
PBS three times, and incubated in 1 % bovine serum
albumin at room temperature for 30 min. Cultures were
incubated with the following primary antibodies overnight
at 4 C: monoclonal mouse anti-human vimentin (1:1000,
Sigma-Aldrich), monoclonal mouse anti-human mito-
chondria (1:1000, Sigma-Aldrich), polyclonal rabbit anti-
human amylase (1:1000, Sigma-Aldrich), polyclonal rabbit
anti-human basic fibroblast growth factor (bFGF, 1:250,
Abcam), and polyclonal sheep anti-human nerve growth
factor (NGF; 1:200, Abcam). After washing with PBS,
cells were incubated with anti-mouse, anti-rabbit or anti-
sheep fluorescein-conjugated secondary antibodies (Alexa
Fluor; Life Technologies) diluted 1:1000 at room temper-
ature for 30 min. For nuclear staining and inclusion, Vec-
tashield mounting medium with DAPI (Vector
Laboratories) was used. For negative controls, primary
antibody was omitted during immunostaining.
Reverse-transcriptase polymerase chain reaction
(RT-PCR)
Reverse-transcriptase polymerase chain reaction was per-
formed to confirm salivary gland marker gene expression
in hSG-fibros, co-SG cells, and cultured tissues. Total RNA
was extracted and purified from each cell type by RNeasy
mini kit (Qiagen, Hilden, Germany). Using 1 lg of total
RNA, cDNAs were synthesized using a high-capacity
cDNA Reverse Transcription kit (Life Technologies).
Platinum PCR SuperMix (Life Technologies) and a Veriti
Thermal Cycler (Life Technologies) were used for PCR
amplification according to the manufacturers’ instructions.
PCR conditions were as follows: initial denaturing step at
95 C for 2 min, 35 repeated cycles of denaturing at 95 C
for 30 s, primer annealing at 54–58 C for 30 s, and
extension at 72 C for 1 min, followed by a final extension
at 72 C for 10 min. PCR products were separated by 2 %
gel electrophoresis (Nippon Gene Co. Ltd., Japan) and
were visualized with UV after ethidium bromide (Life
Technologies) staining.
The following primers were used: amylase, sense 50-
GGG ATT TGG AGG GGT TCA GG-30, antisense 50-TTC
TGT CAC CCG GCC ATT AC-30 (NM_004038); AQP-5,
sense 50-CGG GCT TTC TTC TAC GTG G-30, antisense
50-GCT GGA AGG TCA GAA TCA GCT C-30
(NM_001651); bFGF, sense 50-AGA AGA GCG ACC
CTC ACA TCA-30, antisense 50-CGG TTA GCA CAC
ACT CCT TTG-30 (NM_002006); NGF, sense 50-GGC
AGA CCC GCA ACA TTA CT-30, antisense 50-CAC CAC
CGA CCT CGA AGT C-30 (NM_002506); vimentin, sense
50-GGG ACC TCT ACG AGG AGG AG-30, antisense 50-
CGC ATT GTC AAC ATC CTG TC-30 (NM_003380);
collagen type I, sense 50-CCA AAT CTG TCT CCC CAG
AA-30, antisense 50-TCA AAA ACG AAG GGG AGA TG-
30 (NM_000088); and prostate stem cell antigen (PSCA), a
marker of undifferentiated cells [18], sense 50-TGC TGC
TTG CCC TGT TGA T-30, antisense 50-CCT GTG AGT
CAT CCA CGC A-30 (NM_005672). The internal control
was glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), sense 50-CGT CTT CAC CAC CAT GGA GA-
30, and antisense 50-CGG CCA TCA CGC CAC AGT TT-
30 (NM_002046).
Results
Analysis of cultured cells
Cells isolated from tissues were identified before the
experiment. Cells cultured and isolated from BFPs were
observed under phase contrast microscopy and were spin-
dle shaped (Fig. 1a). Specific cell markers of hBFP-ASCs
characterized by flow cytometry (Fig. 1b) indicated they
were strongly positive for CD44 (100 %), CD90 (99.8 %),
and CD105 (94 %) (multipotent stromal cell markers), but
negative for CD14 (0.1 %) and CD34 (0.03 %) (he-
matopoietic cell markers). To determine hBFP-ASC dif-
ferentiation ability, they were subjected to osteogenic,
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adipogenic, and chondrogenic differentiation. After osteo-
genic induction, alizarin-red-positive mineralized nodules
were observed in induced hBFP-ASCs (Fig. 1c), whereas
no alizarin red staining was observed in controls (Fig. 1f).
After adipogenic induction, clusters of Oil red O-positive
cells were detected (Fig. 1d), but not in controls (Fig. 1g).
After chondrogenic induction, clusters of toluidine-blue-
positive cells were detected in induced cells (Fig. 1e), but
not in controls (Fig. 1h).
Cultured fibroblasts with typical spindle-shaped mor-
phology by phase-contrast microscopy (Fig. 2a) were
analyzed by immunostaining (Fig. 2b) and RT-PCR
(Fig. 2d), which indicated they were hSG-fibros. Amylase
analysis by RT-PCR and immunostaining revealed no
expression, indicating cells isolated from salivary glands
did not include acinar cell components (Fig. 2c,d).
Induction to salivary gland cells by co-culture (co-
SG cells)
Cultured cell morphology was altered at 1 week after co-
culture of hBFP-ASCs with hSG-fibros (Fig. 3a) compared
with culture of hBFP-ASCs alone (Fig. 1a). Cells charac-
terized by immunostaining (Fig. 3b–d) and RT-PCR
(Fig. 3e) indicated salivary-gland-related markers (amylase,
bFGF and NGF) were expressed indicating similar charac-
teristics to salivary glands. AQP-5 expression was not seen
by RT-PCR. Because PSCA expression was not observed,
we concluded differentiation was induced in most cells, and
undifferentiated cells were no longer present. In addition,
amylase activity in salivary gland cells induced to differen-
tiate was higher than in controls. We confirmed induced
differentiation by functional assays (Fig. 7).
Karyotype analysis of co-SG cells
To examine karyotype and chromosomal stability of cul-
tured cells (passage 3), we performed G-banded karyotype
analysis, which showed all samples had a normal (92 %)
karyotype with diploid chromosome number (2n = 46;
Fig. 4).
Transplantation of co-SG cells in vivo
After confirming cells obtained from hBFP-ASCs and
hSG-fibros co-culture were salivary gland cells, they were
transplanted to normal submandibular glands of mice.
About 1 month after transplantation, staining of the trans-
planted side of the submandibular gland with HE and PAS
revealed tissue distinct from mouse salivary gland in the
a 








Fig. 1 Identification of hBFP-ASCs. a Phase-contrast micrograph of
spindle-shaped cells. Scale bar 100 lm. b Flow cytometric analysis
of hBPP-ASCs with antibodies reactive to cell surface markers CD44,
CD90, CD105, CD14 and CD34. Mouse IgG was used as an isotype
control. c–h Differentiation of hBFP-ASCs to osteogenic, adipogenic
and chondrogenic lineages. Scale bars 100 lm. c Alizarin red staining
indicates mineralization after culture in osteogenic induction medium
for 3 weeks. d No mineralized nodule formation was observed in
control medium culture. e Oil red O staining indicates lipid clusters
after culture in adipogenic induction medium for 4 weeks. f No lipid
clusters were observed in control medium. g Toluidine blue indicates
the induced clusters in chondrogenic induction medium for 4 weeks,
h but no induction was seen in control cells
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vicinity of the intrinsic glands within the same sub-
mandibular gland capsule (Fig. 5a–d, asterisk). Further
analysis by immunostaining (asterisk) indicated a collec-
tion of cells positive for human-specific mitochondria and
amylase and negative for mouse-specific AQP-5 (Fig. 5e–
g). RT-PCR of transplanted tissue using human-specific
primers also showed expression of amylase, a salivary
gland marker (Fig. 5h). Moreover, expression of AQP-5,
which was not seen in the co-SG cell state, was observed in
tissues following transplantation. Thus, transplantation of
co-SG cells induced by co-culture of hBFP-ASCs with
hSG-fibros into normal tissues in vivo mediated regenera-
tion of neo-salivary gland tissues that might produce
amylase and have a functional role.
Reconstitution of salivary gland tissues
Samples obtained from co-SG cells reconstituted by 3D
culture examined by HE staining confirmed acinar-like or
duct-like structures formed inside the sponge (Fig. 6a–c).
PAS staining and immunostaining demonstrated the inside
of the duct-like structure was amylase positive (Fig. 6d).
GAPDH Vimenn Collagen type I α-Amylase
a b c 
d 
Fig. 2 Identification of hSG-fibros. a Phase-contrast micrographs of typical spindle shapes. Scale bar 100 lm. b–d Immunostained images.
DAPI (blue), b vimentin, and c amylase (red). d RT-PCR confirmed the cells were human-derived fibroblasts








tessellation. Scale bar 100 lm.
b–d Immunostained images.
DAPI (blue), b amylase (red),
c bFGF (green), and d NGF
(red) indicated salivary gland
marker positivity. e RT-PCR
showed expression of human-
specific salivary gland markers
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Thus, co-SG cells induced by co-culture of hBFP-ASCs
with hSG-fibros formed acinar-like or duct-like structures
that produced amylase in a 3D culture. RT-PCR of these
structures also showed expression of amylase and AQP-5
(salivary gland markers, Fig. 6e). Furthermore, amylase
activity analysis confirmed activity in induced cells and 3D
culture samples (Fig. 7).
Discussion
There are currently no established radical therapies for
atrophied and hypofunctioning salivary glands caused by
age or illness. The main therapeutic options provide
symptom relief (gargles, oral lubricants), or salivary stim-
ulation using medication [3, 5]. These effects are not
adequate and many patients suffer reduced quality of life
associated with decreased saliva production [2, 3]. Recent
studies have focused on regenerative medicine as a radical
therapy for atrophy and hypofunction of salivary glands [1,
4, 19, 20]. Therefore, the transplant of salivary gland cells
differentiated from stem cells in culture to regenerate
salivary gland tissue, particularly solid organs containing
acinar and duct systems, might be a future therapy for
atrophied and hypofunctioning salivary glands. Clinically,
promoting new growth and replacing salivary glands with
cell transplants might be less invasive and more feasible
than transplantation of glandular tissue (organs) formed in
3D cultures.
The most commonly reported method in salivary gland
regenerative medicine is tissue stem cell transplantation [4,
19, 21, 22]. Ductal cells positive for several stem cell
markers in the ductal compartment of salivary glands [4,
23, 24] were transplanted into salivary glands of a mouse
model of radiation exposure to regenerate acinar cells and
restore saliva volume [22, 25]. However, it might be dif-
ficult to obtain sufficient cell numbers because stem cells
must be derived from salivary glands that might already be
atrophied. Therefore, we investigated a method of isolating
and transplanting glandular epithelial cells derived from
normal salivary glands, although transplantation experi-
ments showed that cells in salivary gland tissue similar to
normal cells may not be successfully engrafted [26].
Preparation of transplantable cells with a high regenerative
capacity is therefore desired. However, for isolating stem
cells, individual culture conditions must be established
depending on the condition of the extracted tissue. No
simple, clinically applicable method is thought to exist.
Bone-marrow-derived stem cells were recently shown to
differentiate into epithelial cells in vitro [18, 21, 27–29].
When stem cells isolated from salivary glands were
transplanted in vivo into damaged and atrophied salivary
glands, they remained in tissues and had salivary gland
function [21, 30, 31]. However, issues remain with the
Chromosome number 45 46 Total
Cell number 4 46 50
Fig. 4 Karyotype analysis of
co-SG cells. Maintenance of
normal diploidy was confirmed
by G-band analysis
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establishment of a simple method for regenerative therapy.
For example, even if adequate numbers of stem cells are
transplanted, the number of cells engrafted is limited owing
to inhibition of cell adhesion [26, 32], and tissue regener-
ation does not occur unless a certain level of function
remains before transplantation. In addition, bone marrow
extraction is difficult.
To produce transplantable cells with high regenerative
capacity, we investigated a method to induce differentia-
tion into salivary gland cells by co-culturing hBFP-ASCs
with hSG-fibros. These differentiated cells from hBFP-
ASCs co-culture were transplanted into normal mouse
submandibular glands to form new salivary gland tissues.
We showed that stem cells with pluripotent potential iso-
lated from BFPs extracted during dentistry are a viable
source of transplantable cells for regenerative medicine.
Thus, salivary gland cells induced to differentiate by the
co-culture system can be grafted and regenerate tissue
without inducing cell inhibitory mechanisms. Furthermore,
this method has the following advantages: (1) stable phe-
notype; and (2) induction, differentiation and transplanta-
tion can be repeated because cells can be cryopreserved.
The amylase assay kit is intended for quantifying
amylase metabolites. Thus, it is possible to induce the
differentiation of salivary gland cells that secrete amylase
with physiological activity.
Regarding reconstruction of tissues in 3D culture, sali-
vary gland cells induced to differentiate by the co-culture
method were confirmed in vitro to produce salivary-gland-
like tissues. A high tissue regenerative capacity was also
seen in vivo. Improving culture methods will enhance this
potential source of transplantable tissues for salivary
glands to repair partial defects from surgery, if structure
precision can be increased. Thus, we are planning to
investigate whether the stability of salivary gland tissue
formed in 3D culture can be maintained in vivo.
For clinical applications, BFP and salivary gland tissues
should be extracted with minimal invasiveness from
patients with atrophied and hypofunctioning salivary
glands, to isolate stem cells and fibroblasts from each tis-
sue, induce their differentiation into salivary gland cells by
co-culture, and return the cells to the original patient. For
greater safety, we regeneration of hypofunctioning salivary
glands might be assisted by administering conditioned























Fig. 5 Transplantation of co-SG cells in vivo. a, b HE-stained
images. c, d PAS-stained images. Regeneration of tissue (asterisk) in
mice that differs in the vicinity of intrinsic glands within the same
capsule. Asterisk regeneration of tissue, m submandibular gland,
l sublingual gland. e–g Immunostained images. DAPI (blue),
e human-specific mitochondria (green), f amylase (red), and
g AQP-5 (red, mouse-specific antibody used) merged images of
mitochondria and amylase, confirming the tissue was formed from
human cells. Asterisk regeneration of tissue, m salivary gland of
mouse. h RT-PCR showed expression of salivary gland markers.
Primers for human-specific sequences were used
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medium from salivary gland cells induced to differentiate
by co-culture. We aim to develop a treatment using con-
ditioned medium without cell components.
In conclusion, we successfully induced differentiation of
cells to salivary gland-type cells by co-culturing hBFP-
ASCs with hSG-fibros. This method is minimally invasive
and safe for tailor-made salivary gland regeneration
therapy.
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